These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27464292)

  • 21. Translation and validation of the arabic version of the myasthenia gravis activities of daily living scale.
    Alanazy MH; Abuzinadah AR; Muayqil T
    Muscle Nerve; 2019 May; 59(5):583-586. PubMed ID: 30697753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatigue in myasthenia gravis: risk factors and impact on quality of life.
    Hoffmann S; Ramm J; Grittner U; Kohler S; Siedler J; Meisel A
    Brain Behav; 2016 Oct; 6(10):e00538. PubMed ID: 27781147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new and easily used modified myasthenia gravis score.
    Sathirapanya P; Wiputhanuphongs K; Liabsuetrakul T; Khanittanuphong P; Keeratichananont W
    Neuromuscul Disord; 2020 Aug; 30(8):656-660. PubMed ID: 32771266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers.
    Barnett C; Katzberg H; Nabavi M; Bril V
    J Clin Neuromuscul Dis; 2012 Jun; 13(4):201-5. PubMed ID: 22622164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The modified rankin scale to assess disability in myasthenia gravis: Comparing with other tools.
    Farrugia ME; Carmichael C; Cupka BJ; Warder J; Brennan KM; Burns TM
    Muscle Nerve; 2014 Oct; 50(4):501-7. PubMed ID: 24639179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing the health state classification system for a condition-specific preference-based measure for patients with myasthenia gravis.
    Xu RH; Yu S; Liu J; Zhang S; Dong D
    Disabil Rehabil; 2023 Oct; 45(20):3366-3372. PubMed ID: 36102606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality-of-life and treatment targets in myasthenia gravis.
    Utsugisawa K; Suzuki S; Nagane Y; Masuda M; Murai H; Imai T; Tsuda E; Konno S; Nakane S; Suzuki Y; Fujihara K; Suzuki N
    Muscle Nerve; 2014 Oct; 50(4):493-500. PubMed ID: 24536040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The MG Composite: A valid and reliable outcome measure for myasthenia gravis.
    Burns TM; Conaway M; Sanders DB;
    Neurology; 2010 May; 74(18):1434-40. PubMed ID: 20439845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigation and analysis of health-related quality of life in myasthenia gravis patients with myasthenia gravis quality of life-15 Chinese version].
    Miao XH; Lian ZY; Liu J; Chen HX; Shi ZY; Zhou HY; Yang R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):514-520. PubMed ID: 29930422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability and Validity of Turkish Myasthenia Gravis-Activities of Daily Living Scale.
    Karanfil E; Salcı Y; Fil-Balkan A; Bekircan-Kurt CE; Erdem Özdamar S; Armutlu K
    OTJR (Thorofare N J); 2021 Apr; 41(2):101-107. PubMed ID: 33016212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brazilian-Portuguese translation, cross-cultural adaptation and validation of the Myasthenia Gravis Composite scale. A multicentric study.
    Oliveira EF; Lima VC; Perez EA; Polaro MN; Valério BC; Pereiro JR; Nacif SR; Oliveira CS; Oliveira AS; Oliveira LV
    Arq Neuropsiquiatr; 2016 Nov; 74(11):914-920. PubMed ID: 27901257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of the Myasthenia Gravis Impairment Index.
    Barnett C; Bril V; Kapral M; Kulkarni A; Davis AM
    Neurology; 2016 Aug; 87(9):879-86. PubMed ID: 27402891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of a single simple question in the evaluation of patients with myasthenia gravis.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V
    Muscle Nerve; 2018 Feb; 57(2):240-244. PubMed ID: 28590545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of the scale for symptom clusters in patients with myasthenia gravis.
    Shen F; Hu LH; Huang HS; Li L
    BMC Neurol; 2023 May; 23(1):196. PubMed ID: 37208623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study.
    Nagane Y; Murai H; Imai T; Yamamoto D; Tsuda E; Minami N; Suzuki Y; Kanai T; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Aoki M; Utsugisawa K
    BMJ Open; 2017 Feb; 7(2):e013278. PubMed ID: 28235967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis: sleep quality, quality of life, and disease severity.
    Martínez-Lapiscina EH; Erro ME; Ayuso T; Jericó I
    Muscle Nerve; 2012 Aug; 46(2):174-80. PubMed ID: 22806365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative Myasthenia Gravis Score: a Brazilian multicenter study for translation, cultural adaptation and validation.
    Oliveira EF; Valério BCO; Cavalcante V; Urbano JJ; Silva AS; Polaro MN; Nacif SR; Oliveira CS; Resende MBD; Oliveira ASB; Oliveira LVF
    Arq Neuropsiquiatr; 2017 Jul; 75(7):457-463. PubMed ID: 28746433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication adherence in patients with myasthenia gravis in Brazil: a cross-sectional study.
    Vitturi BK; Pellegrinelli A; Valerio BCO
    Acta Neurol Belg; 2020 Feb; 120(1):83-89. PubMed ID: 31555980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).
    Pasqualin F; Barnett C; Guidoni SV; Albertini E; Ermani M; Bonifati DM
    Neurol Sci; 2022 Mar; 43(3):2059-2064. PubMed ID: 34505205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.